Sunshine Biopharma Inc. (SBFMW) stock
SBFMWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFM
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.03+0.00 (+2.00%)
Close on Oct 30, 2026Market cap $11.36MP/E –Yield –
Sunshine Biopharma statistics
79 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Oct 30, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.44
- 2.47
Enterprise valuationIndustry
- EV / Sales
- -0.07
- 2.70
Share statisticsIndustry
- Shares Change (YoY)
- 96.8%
- 10.8%
- Shares Change (QoQ)
- -51.3%
- 0.54%
- Float
- 4M
- 49M
- Shares Held by Insiders
- 1.76%
- 11.4%
- Shares Held by Institutions
- 2.08%
- 56.1%
Short sellingIndustry
- Short Interest
- 131,478
- –
- Short Interest Change
- 461.6%
- 0.60%
- Days to Cover
- 1.00
- 4.58
Stock price statisticsIndustry
- 52-Week High
- $464.00
- –
- 52-Week Low
- $0.20
- –
- 20-Day Moving Average
- $3.39
- –
- 50-Day Moving Average
- $10.99
- –
- 200-Day Moving Average
- $101.42
- –
- Average True Range (14)
- $2.76
- –
- Price Change (1 Week)
- -2.33%
- 1.30%
- Price Change (1 Month)
- 326.1%
- -7.60%
- Price Change (3 Months)
- -87.5%
- -14.4%
- Price Change (6 Months)
- -72.2%
- -19.7%
- Price Change (YTD)
- -98.8%
- -19.6%
- Price Change (1 Year)
- -99.2%
- -21.9%
- Price Change (3 Years)
- -95.1%
- -22.6%
- Price Change (5 Years)
- -81.7%
- -75.5%
- Price Change (10 Years)
- 46.5%
- -56.5%
- Average Volume (10 Days)
- 306,691
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 469,054
- –
- Relative Volume
- 0.24
- 0.73
- Relative Strength Index (14)
- 45.5
- 44.2
- Volatility (1 Year)
- 7328.2%
- 79.5%
MarginsIndustry
- Pretax Margin
- -15.7%
- -13.0%
- EBITDA Margin
- -15.7%
- -30.5%
- FCF Margin
- -15.2%
- -9.06%
Returns on capitalIndustry
- Return on Equity (ROE)
- -21.9%
- -53.1%
- Return on Assets (ROA)
- -17.8%
- -40.9%
- Return on Invested Capital (ROIC)
- -31.9%
- -33.0%
- Return on Capital Employed (ROCE)
- -21.0%
- -38.6%
Financial positionIndustry
- Current Ratio
- 5.46
- 3.30
- Quick Ratio
- 3.16
- 2.39
GrowthIndustry
- Revenue Growth (YoY)
- -2.74%
- 5.65%
- Revenue Growth (3Y CAGR)
- 102.9%
- 2.17%
- Revenue Growth (5Y CAGR)
- 247.7%
- 6.47%
EfficiencyIndustry
- Asset Turnover
- 1.08
- 0.39
- Inventory Turnover
- 1.96
- 2.68
- Revenue Per Employee
- $706.94K
- $405.05K
- Profits Per Employee
- -$116.65K
- -$705.27K
- Employee Count
- 50
- 75
Income statement (TTM)Industry
- Pretax Income
- -$5.56M
- -$14.23M
Balance sheetIndustry
- Net Cash (Debt)
- $13.75M
- $15.31M
- Net Cash Per Share
- $3.55
- $0.66
- Equity (Book Value)
- $27.54M
- $48.79M
- Book Value Per Share
- $7.10
- $1.36
- Tangible Book Value
- $25.70M
- $23.91M
- Working Capital
- $25.05M
- $74.41M
Cash flow (TTM)Industry
- Capital Expenditures
- -$19.15K
- -$1.07M
- FCF Per Share
- -$1.39
- -$0.41
Dividends and yieldsIndustry
- Earnings Yield
- -51.3%
- -20.7%
- FCF Yield
- -47.3%
- -8.69%
Taxes and interestIndustry
- Income Tax
- $270.94K
- $86.50K
Scores and fair valueIndustry
- Altman Z-Score
- -0.75
- 0.25
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 30, 2026. The S&P 500 is measured by the SPY fund.
| Period | SBFMW | S&P 500 | Difference | SBFMW per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -51.3% | -0.9% | −50.4 pts | ||
| 3 months | -40.7% | +2.1% | −42.8 pts | ||
| Year to date | -86.6% | +11.7% | −98.3 pts | ||
| 1 year | -91.2% | +12.4% | −103.6 pts | ||
| 3 years | -91.2% | +88.6% | −179.8 pts | -55.5% | +23.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 15, 2026.
0M SBFMW shares were sold short on Oct 15, 2026, up 0.0% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 18.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 15, 2026 | 773 | 0.0% | 5,861 | 1.0 |
| Sep 30, 2026 | 773 | 0.0% | 2,106 | 1.0 |
| Sep 15, 2026 | 773 | 0.0% | 38 | 20.3 |
| Aug 31, 2026 | 773 | 0.0% | 805 | 1.0 |
| Aug 14, 2026 | 773 | -85.7% | 190 | 4.1 |
| Jul 31, 2026 | 5,398 | -7.2% | 6,154 | 1.0 |
| Jul 15, 2026 | 5,818 | +652.7% | 5,883 | 1.0 |
| Jun 30, 2026 | 773 | -26.1% | 45,079 | 1.0 |
| Jun 15, 2026 | 1,046 | -20.6% | 14,585 | 1.0 |
| May 29, 2026 | 1,317 | -76.6% | 26,884 | 1.0 |
| May 15, 2026 | 5,626 | -0.1% | 430 | 13.1 |
| Apr 30, 2026 | 5,634 | 0.0% | 0 | 1000.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.